Rep. Jonathan L. Jackson Sells Tenet Healthcare Corporation (NYSE:THC) Stock

Representative Jonathan L. Jackson (Democratic-Illinois) recently sold shares of Tenet Healthcare Corporation (NYSE:THC). In a filing disclosed on May 27th, the Representative disclosed that they had sold between $15,001 and $50,000 in Tenet Healthcare stock on April 20th. The trade occurred in the Representative’s “MORGAN STANLEY TRUST ACCOUNT” account.

Representative Jonathan L. Jackson also recently made the following trade(s):

• Sold $50,001 – $100,000 in shares of Visa (NYSE:V) on 4/24/2026.
• Sold $1,001 – $15,000 in shares of O’Reilly Automotive (NASDAQ:ORLY) on 4/24/2026.
• Purchased $15,001 – $50,000 in shares of Simon Property Group (NYSE:SPG) on 4/20/2026.
• Sold $1,001 – $15,000 in shares of Tenet Healthcare (NYSE:THC) on 4/15/2026.
• Purchased $1,001 – $15,000 in shares of BP (NYSE:BP) on 3/20/2026.
• Sold $15,001 – $50,000 in shares of O’Reilly Automotive (NASDAQ:ORLY) on 3/19/2026.
• Purchased $15,001 – $50,000 in shares of BP (NYSE:BP) on 3/19/2026.
• Sold $1,001 – $15,000 in shares of Amazon.com (NASDAQ:AMZN) on 3/9/2026.

Tenet Healthcare Trading Up 0.9%

Shares of THC stock opened at $174.83 on Friday. The stock has a 50-day simple moving average of $189.94 and a 200 day simple moving average of $201.87. Tenet Healthcare Corporation has a fifty-two week low of $146.60 and a fifty-two week high of $247.21. The stock has a market capitalization of $15.06 billion, a P/E ratio of 9.09, a P/E/G ratio of 1.14 and a beta of 1.30. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, beating the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The business had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.39 billion. During the same quarter last year, the business posted $4.36 earnings per share. The company’s quarterly revenue was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, sell-side analysts expect that Tenet Healthcare Corporation will post 17.67 earnings per share for the current fiscal year.

Insider Activity at Tenet Healthcare

In other news, insider R. Scott Ramsey sold 8,017 shares of the firm’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $232.70, for a total transaction of $1,865,555.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Thomas W. Arnst sold 8,000 shares of the firm’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $238.85, for a total value of $1,910,800.00. Following the sale, the executive vice president directly owned 12 shares of the company’s stock, valued at $2,866.20. This trade represents a 99.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 55,155 shares of company stock worth $12,459,105. 0.97% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on THC shares. Guggenheim reduced their target price on Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating for the company in a report on Friday, May 1st. Morgan Stanley set a $254.00 target price on Tenet Healthcare in a report on Friday, May 1st. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Tenet Healthcare in a report on Friday, March 27th. TD Cowen reaffirmed a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. Finally, Royal Bank Of Canada reduced their target price on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a report on Friday, May 1st. Nineteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $244.16.

Institutional Investors Weigh In On Tenet Healthcare

Hedge funds have recently bought and sold shares of the business. WCM Investment Management LLC lifted its stake in Tenet Healthcare by 244.4% in the 3rd quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock worth $102,657,000 after acquiring an additional 362,083 shares in the last quarter. AlphaQuest LLC lifted its stake in Tenet Healthcare by 238.3% in the 3rd quarter. AlphaQuest LLC now owns 5,965 shares of the company’s stock worth $1,211,000 after acquiring an additional 4,202 shares in the last quarter. Winnow Wealth LLC purchased a new stake in Tenet Healthcare in the 3rd quarter worth about $1,129,000. Savant Capital LLC raised its stake in shares of Tenet Healthcare by 27.5% during the 3rd quarter. Savant Capital LLC now owns 16,894 shares of the company’s stock worth $3,430,000 after purchasing an additional 3,647 shares in the last quarter. Finally, Caption Management LLC purchased a new stake in shares of Tenet Healthcare during the 3rd quarter worth about $5,650,000. 95.44% of the stock is owned by hedge funds and other institutional investors.

About Representative Jackson

Jonathan Jackson (Democratic Party) is a member of the U.S. House, representing Illinois’ 1st Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.

Jackson (Democratic Party) is running for re-election to the U.S. House to represent Illinois’ 1st Congressional District. He declared candidacy for the 2026 election.

Jonathan Jackson was born in Chicago, Illinois. Jackson graduated from Whitney Young High School. He earned an M.B.A. from Northwestern University. Jackson’s career experience includes working as an investment analyst and an entrepreneur.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.